Navigation Links
Sensus Healthcare Announces its Exhibitor Attendance at the 71st Annual American Academy of Dermatology Meeting
Date:2/22/2013

BOCA RATON, Fla., Feb. 22, 2013 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 71st Annual American Academy of Dermatology Meeting in Miami Beach, FL on March 1-5, 2013. Visit booth #2701 to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™. The SRT-100 offers unique features and benefits providing Dermatologists a non-invasive option for treating their patients who are diagnosed with skin cancer!

(Logo: http://photos.prnewswire.com/prnh/20130222/FL64841LOGO )

We cordially invite all AAD attendees to visit our booth (#2701) at the upcoming 71st Annual Academy of Dermatology Meeting in Miami Beach, FL and rediscover superficial radiotherapy (SRT). We are proud to feature our SRT-100™ non-invasive treatment system and demonstrate the impact it can have on your practice by providing your patients with a non-invasive treatment option while at the same time increasing your productivity and realizing an excellent ROI! "We are very excited by the feedback we are getting from our Dermatology customers. They are experiencing excellent outcomes as their patients are very happy with the results and they feel their investment in the SRT-100 was well worth it," declared Joe Sardano , President/CEO, Sensus Healthcare.    
See you in Miami!

About Sensus Healthcare:  
Sensus Healthcare is the worldwide leader dedicated to Superficial Radiotherapy Technology (SRT). The featured SRT-100 System is the most advanced non-invasive technology used by Dermatologists and Radiation Oncologists throughout the world in treating Basal Cell (BCC) and Squamus Cell (SCC) Carcinomas. The SRT-100 features Sharp
'/>"/>

SOURCE Sensus Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
6. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
7. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
8. ViroPharma to Participate in Two December Healthcare Investor Conferences
9. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
10. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
11. Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. ... on providing advanced testing solutions for the detection of ... will present at the Sidoti & Company Emerging Growth ... will be held at the New York Marriott Marquis. ... will be available through the investor relations section of ...
(Date:8/26/2015)... FRANCISCO , Aug. 26, 2015  Platform ... that it has received a $1.5M Phase II ... (NIH) to further develop its therapeutic agent to ... clinical need in end stage renal disease (ESRD) ... the National Institute of Diabetes and Digestive and ...
(Date:8/26/2015)... 2015 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has been informed that Magnum ... owned by Mr. Yuen Kam, chairman of the board ... shares (the "Shares") of  Excellent China Healthcare Investment Limited ...
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, a ... business relationships with local sponsors in southern California. The Clinical Trial Management Expert CRO ... processes and regulatory pathways., , Stem Cell Meeting on ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
... Nets to Prevent Serious Health Hazards ... Associated with Diethylene ... Pharmacopeial (USP),Convention today announced a revised Glycerin monograph in ... United States. The,revision strengthens safety nets to prevent serious ...
... The following was issued,today by the Greater Baltimore ... CEO, Greater Baltimore Committee, 140 company owners, executives ... The third annual Greater Baltimore Region Bioscience Awards, ... / Breakfast & Registration, 8:45 - 9:30 a.m. ...
... March 17 Mercury Therapeutics,Inc. (MTI), a ... protein,kinase targeted drugs, announces that it has ... advise on its strategic and partnering,opportunities, with ... shareholders., This appointment follows a significant ...
Cached Biology Technology:USP Announces Revised Glycerin Monograph 2USP Announces Revised Glycerin Monograph 3Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 3
(Date:8/10/2015)... Germany , August 10, 2015 ... in Eye Tracking Technology for more than two decades, ... Platform for integration into all consumer display formats. The ... seamless integration of eye tracking into consumer tablets, laptops, ... reality smart glasses. Omnivision,s leading sensor technology contributes to ...
(Date:8/6/2015)... CITY, Calif. , Aug. 6, 2015 /PRNewswire/ ... Valley) will visit Crossmatch ™ to learn ... networks and protect data. Crossmatch is a world ... whose technologies and expertise are helping federal agencies ... efficiency and security.   "The vast ...
(Date:8/6/2015)... SAN JOSE, Calif. , Aug. 6, 2015 ... the leading developer of human interface solutions, today ... and TouchPad technologies on Windows 10. Microsoft leveraged ... fundamental to the operating system. ... and drivers are fully certified with Microsoft,s Precision ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... A drug being tested to treat cancer could also ... at the University of Edinburgh found that the drug ... exacerbate symptoms associated with asthma. The findings could lead ... are resistant to steroids, which are commonly used in asthma ...
... cancer mortality in children. Even if a cure is ... treatment which can be harmful to the developing brain. ... treatment methods. The most important childhood brain tumors are ... patients each year in Germany, and pylocytic astrocytoma, which ...
... German and Portuguese . So Paulo/ ... impact on climate change than has previously been thought. The combined ... after habitat fragmentation can be up to 40 per cent less ... This is the conclusion reached by German and Brazilian researchers who ...
Cached Biology News:Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 2Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 3
... for interferons are cytopathic effect inhibition assays, also ... types include; tissue culture supernatents; serum from PK ... one unit is defined as the quantity of ... effect of viral infection by 50%. ...
Request Info...
...
... is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long ... new radiolabeled ligands selected to keep pace ... range of products and services for receptor ... state-of-the-art radioligands. If you do not find ...
Biology Products: